科学图书馆
-
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trialde Winter RJ, Katagiri Y, Serruys PW et al. -
De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health statusQintar M, Hirai T, Salisbury AC et al.
-
LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and ModulationPothineni NVK, Karathanasis SK, Mehta JL et al.
-
Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance DocumentE Spitzer, E Mc Fadden, P Vranckx et al.
-
Cardiac Sympathetic Denervation for Refractory Ventricular ArrhythmiasM. Vaseghi, K. Shivkumar et al
-
Prospective Elimination of Distal Coronary Sinus to Left Atrial Connection for Atrial Fibrillation Ablation (PRECAF) Randomized Controlled TrialL Kuo , DS Frankel, S Nazarian et al.
-
Stent fracture is associated with a higher mortality in patients with type-2 diabetes treated by implantation of a second-generation drug-eluting stentZ Ge, ZZ Liu, SL Chen et al
-
Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part SeriesNiemann B, Newby DE, Kovacic JC et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
